NCT00222534View on ClinicalTrials.gov

Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Respiratory InsufficiencyAlkalosis
Interventions
DRUG

Acetazolamide

DRUG

Placebo

Trial Locations (5)

Unknown

Department of Respiratory Medicine, Haukeland University Hospital, Bergen

Department of Internal Medicine, Sorlandet Sykehus Kristiansand, Kristiansand

Department of Internal Medicine, St.Olav's Hospital, Trondheim

0514

Department of Internal Medicine, Aker University Hospital, Oslo

NO-0407

Ullevaal University Hospital, Dept. of Respiratory Medicine, Oslo

All Listed Sponsors
lead

University of Oslo School of Pharmacy

OTHER

NCT00222534 - Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis | Biotech Hunter | Biotech Hunter